David Lligé
Impact in
-
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Immune cells in cancer
-
- Eosinophilic Esophagitis
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 2
- Oncology 4
- Pancreatic and Hepatic Oncology Research 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Giuliana Magri (1 shared paper)Aleksey Chudnovskiy (1 shared paper)Montserrat Cols (1 shared paper)Sidonia Fagarasan (1 shared paper)Sergi Serrano (1 shared paper)Juan I. Aróstegui (1 shared paper)Linda Cassis (1 shared paper)Maurizio Gentile (1 shared paper)
In The Last Decade
David Lligé
9 papers receiving 315 citations
Peers
Comparison fields: 5 of 59
- Immunology 210
- Surgery 90
- Clinical Biochemistry 13
- Molecular Biology 80
- Oncology 30
Countries citing papers authored by David Lligé
This map shows the geographic impact of David Lligé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lligé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lligé more than expected).
Fields of papers citing papers by David Lligé
This network shows the impact of papers produced by David Lligé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lligé. The network helps show where David Lligé may publish in the future.
Co-authors
The 25 scholars most cited alongside David Lligé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 221 | |
| 2 | 2019 | 35 | |
| 3 | 2005 | 29 | |
| 4 | 2019 | 14 | |
| 5 | 2005 | 12 | |
| 6 | 2007 | 2 | |
| 7 | 2020 | 2 | |
| 8 | 2019 | 1 | |
| 9 | 2007 | 1 |
About David Lligé
David Lligé is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Surgery, having authored 9 papers that have together received 317 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Phagocytosis and Immune Regulation (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Glycogen Storage Diseases and Myoclonus (2 papers), Peptidase Inhibition and Analysis (2 papers), Metabolism and Genetic Disorders (1 paper) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Immunology (210 citations), Surgery (90 citations), Clinical Biochemistry (13 citations), Molecular Biology (80 citations) and Oncology (30 citations). David Lligé has collaborated with scholars based in Spain, Italy and China. Frequent co-authors include Giuliana Magri, Aleksey Chudnovskiy, Montserrat Cols, Sidonia Fagarasan, Sergi Serrano, Juan I. Aróstegui, Linda Cassis, Maurizio Gentile, Miriam Mérad and Andrea Cerutti. Their work appears in journals such as FEBS Letters, Nature Immunology, Annals of Translational Medicine, Cell Communication and Signaling and European Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.